A exploratory phase II study of SOX followed by interval S-1 alone therapy for advanced gastric cancer: Stop and Go study
Not Applicable
- Conditions
- advanced gastric cancer
- Registration Number
- JPRN-UMIN000023527
- Lead Sponsor
- Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1. Drug allergy 2. Peripheral neurodisturvance 3. GI tract bleeding 4. Continuation of phenitoin, warfain 5. Uncontrollable infection 6. Interstitial pneumonia 7. Other cancers 8. DPD deficiency 9. Family planning 10. Inappropriate patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression-free survival
- Secondary Outcome Measures
Name Time Method response rate, overall survival, toxicity